Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanna Rosengren

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Arthritis Research & Therapy|April 13, 2010
Platelet-derived growth factor and transforming growth factor beta synergistically potentiate inflammatory mediator synthesis by fibroblast-like synoviocytesSanna Rosengren, Maripat Corr, David L Boyle
Clinical and Diagnostic Laboratory Immunology|November 11, 2003
Measurement of inflammatory biomarkers in synovial tissue extracts by enzyme-linked immunosorbent assaySanna Rosengren, Gary S Firestein, David L Boyle
Methods in Molecular Medicine|October 24, 2007
Acquisition, culture, and phenotyping of synovial fibroblastsSanna Rosengren, David L Boyle, Gary S Firestein
Annals of the Rheumatic Diseases|November 29, 2011
The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferonSanna Rosengren, Maripat Corr, Gary S Firestein, et al.
Arthritis and Rheumatism|August 12, 2011
CXCL13 as a marker for outcome of rheumatoid arthritis: comment on the article by Meeuwisse et alSanna Rosengren, Kenneth C Kalunian, Arthur Kavanaugh, et al.
Arthritis and Rheumatism|February 1, 2006
PUMA regulation and proapoptotic effects in fibroblast-like synoviocytesHoon-Suk Cha, Sanna Rosengren, David L Boyle, et al.
Kidney International|April 25, 2008
Modulation of melanocortin signaling ameliorates uremic cachexiaWai W Cheung, Sanna Rosengren, David L Boyle, et al.
Rheumatology (Oxford, England)|November 25, 2010
CXCL13: a novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritisSanna Rosengren, Nathan Wei, Kenneth C Kalunian, et al.
Arthritis Research & Therapy|December 19, 2003
Quantitative biomarker analysis of synovial gene expression by real-time PCRDavid L Boyle, Sanna Rosengren, William Bugbee, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 15, 2018
Recombinant Human PH20: Baseline Analysis of the Reactive Antibody Prevalence in the General Population Using Healthy SubjectsSanna Rosengren, Jennifer Souratha, Dave Conway, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Arthritis Research & Therapy|April 13, 2010
Platelet-derived growth factor and transforming growth factor beta synergistically potentiate inflammatory mediator synthesis by fibroblast-like synoviocytesSanna Rosengren, Maripat Corr, David L Boyle
Clinical and Diagnostic Laboratory Immunology|November 11, 2003
Measurement of inflammatory biomarkers in synovial tissue extracts by enzyme-linked immunosorbent assaySanna Rosengren, Gary S Firestein, David L Boyle
Methods in Molecular Medicine|October 24, 2007
Acquisition, culture, and phenotyping of synovial fibroblastsSanna Rosengren, David L Boyle, Gary S Firestein
Annals of the Rheumatic Diseases|November 29, 2011
The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferonSanna Rosengren, Maripat Corr, Gary S Firestein, et al.
Arthritis and Rheumatism|August 12, 2011
CXCL13 as a marker for outcome of rheumatoid arthritis: comment on the article by Meeuwisse et alSanna Rosengren, Kenneth C Kalunian, Arthur Kavanaugh, et al.
Arthritis and Rheumatism|February 1, 2006
PUMA regulation and proapoptotic effects in fibroblast-like synoviocytesHoon-Suk Cha, Sanna Rosengren, David L Boyle, et al.
Kidney International|April 25, 2008
Modulation of melanocortin signaling ameliorates uremic cachexiaWai W Cheung, Sanna Rosengren, David L Boyle, et al.
Rheumatology (Oxford, England)|November 25, 2010
CXCL13: a novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritisSanna Rosengren, Nathan Wei, Kenneth C Kalunian, et al.
Arthritis Research & Therapy|December 19, 2003
Quantitative biomarker analysis of synovial gene expression by real-time PCRDavid L Boyle, Sanna Rosengren, William Bugbee, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 15, 2018
Recombinant Human PH20: Baseline Analysis of the Reactive Antibody Prevalence in the General Population Using Healthy SubjectsSanna Rosengren, Jennifer Souratha, Dave Conway, et al.
Pageof 3